Clinical Trials Logo

Filter by:
NCT ID: NCT05078541 Completed - Clinical trials for Radiofrequency Ablation

Radiofrequency Ablation for Warthin's Tumor

Start date: October 20, 2021
Phase: N/A
Study type: Interventional

This study is a safety and feasibility study to determine if ultrasound guided radiofrequency ablation of parotid Warthin's tumor under local anesthesia is a safe and effective procedure compared to Parotidectomy while using less resources.

NCT ID: NCT05075876 Completed - Healthy Volunteers Clinical Trials

Bioequivalence Study in Healthy Chinese Subjects Comparing SP-01 (Granisetron Patch) Manufactured at Two Different Sites

Start date: October 13, 2021
Phase: Phase 1
Study type: Interventional

This study is an open-label, single-center, two-period, two-sequence crossover study to assess the bioequivalence of SP-01 (Sancuso®: Granisetron Patch) manufactured at two different sites. Either the test product, namely SP-01-K, or reference product, namely SP-01-A, will be applied to the subject once in each period.

NCT ID: NCT05073861 Completed - Clinical trials for Educational Problems

The Effect of Blend-learning in STEM in Young Children's Affective, Cognitive, and Academic Outcomes

Start date: July 5, 2021
Phase: N/A
Study type: Interventional

The study is a randomised controlled trial that investigates the effectiveness of an online app-based STEM programme on improving Hong Kong primary school students' affective, cognitive, and academic outcomes.

NCT ID: NCT05072405 Completed - Drug Interaction Clinical Trials

The Interaction of Herbs and Statins

Start date: January 11, 2013
Phase: Phase 4
Study type: Interventional

This project includes two separate pharmacokinetic studies with simvastatin and rosuvastatin, respectively. Each study is an open-label, single-dose, randomized, three-phase (no herbs, with green tea, with soy isoflavones) clinical pharmacokinetic study design with a wash-out of at least 4-weeks between phases. The aim is to examine whether green tea extract and soy isoflavones affect the pharmacokinetics of simvastatin and rosuvastatin in healthy subjects and whether these interactions are influenced by polymorphisms in the relevant drug transporters, solute carrier 1B1 (SLCO1B1) and adenosine triphosphate (ATP) binding cassette G2 (ABCG2) and to identify whether polymorphisms in drug transporters influence the pharmacokinetics of simvastatin and rosuvastatin. After informed consent is obtained, subjects are required to abstain from any prescription or non-prescription medications 2 weeks before and throughout the study. Subjects are given a single dose of simvastatin 20 mg (Zocor®, MSD) or rosuvastatin 10 mg (Crestor®, Astra Zeneca) on 3 occasions: 1. without herbs; 2. with green tea extract; 3. with soy isoflavones extract. The green tea extract and soy isoflavones extract are given at a dose containing epigallocatechin gallate (EGCG) 800 mg once daily or isoflavones 120 mg once daily for 14 days before statin dosing with at least 4-week washout period between phases. Blood samples are taken at intervals from 0 to 24 hours on the statin dosing days. During the study, subjects are reminded frequently of the requirements on diet.

NCT ID: NCT05059834 Completed - Anxiety Generalized Clinical Trials

Feasibility Study for Online Mindfulness for GAD

Start date: October 15, 2021
Phase: N/A
Study type: Interventional

Method: . Forty patients with general anxiety disorder will be randomized in 1:1 ratio to the online resource plus usual care, and to usual care control group by stratified block randomization. Measurements including 7-item Generalized Anxiety Disorder questionnaire, 9-item Patient Health Questionnaire, Penn State Worry questionnaire, and Five Facet Mindfulness Questionnaire will be made at baseline and at 2-month. Rate of recruitment, drop out and website usage will be collected. All patients in the intervention arm will be interviewed to assess the clarity of the app and user experience. The scores between the two arms will be compared by t-test and the transcripts of the patient interviews will be analysed using thematic analysis

NCT ID: NCT05057923 Completed - COVID-19 Pneumonia Clinical Trials

The Development of a COVID19 Oral Vaccine Consisting of Bacillus Subtilis Spores

Start date: July 10, 2021
Phase: N/A
Study type: Interventional

This is a study trial to assess the effectiveness of the immune response stimulated by the genetically engineered Bacillus subtilis which express and display Spike protein of the SARS-COV2 on the spore coat.

NCT ID: NCT05056428 Completed - Mental Health Issue Clinical Trials

Effects of Mindfulness Training on Emotional Care Strategies

Start date: September 25, 2021
Phase: N/A
Study type: Interventional

Teachers in Hong Kong are susceptible to professional stress and its associated psychosomatic illnesses. To enhance teachers' well-being, mindfulness training is conducted in local schools. The present study is a randomized controlled trial to investigate 1) the effects of mindfulness training on teachers' well-being (i.e. general health, positive affect, stress, negative affect); 2) whether decentering strategy (vs. cognitive reappraisal strategy) is nurtured by mindfulness practice; and 3) whether decentering instead of cognitive reappraisal is the mediator that explains the impact of mindfulness on well-being. Participants will be randomized to either intervention (8-week .b Foundations course) or waiting-list control condition.

NCT ID: NCT05046691 Completed - Mental Health Issue Clinical Trials

Mindfulness, Compassion and Self-compassion

Start date: October 1, 2021
Phase: N/A
Study type: Interventional

Teachers in Hong Kong are susceptible to professional stress and its associated psychosomatic illnesses. To enhance teachers' well-being, mindfulness training is conducted in local schools. The present study is a randomized controlled trial to explore 1) the relationship between mindfulness, common humanity, self-compassion, compassion, and well-being of school teachers; 2) whether mindfulness and common humanity are the antecedents of self-compassion and compassion; 3) the conditions under which compassion and self-compassion are highly correlated. Participants will be randomized to either intervention (8-week .b Foundations course) or waiting-list control condition. They will complete an online survey before (baseline), after (post-intervention), and two-months (follow-up) after the intervention.

NCT ID: NCT05045300 Completed - Clinical trials for Musculoskeletal Diseases or Conditions

Paraneural Sheath & Fascial Compartments Surround Brachial Plexus at Supraclavicular Fossa During Selective Trunk Block

Start date: September 20, 2021
Phase:
Study type: Observational

The aim of this retrospective study is to define the paraneural (fascial) sheath and fascial compartments that surround the brachial plexus at the supraclavicular fossa by reviewing previous ultrasound images from cases that have undergone ultrasound guided selective trunk brachial plexus block.

NCT ID: NCT05032664 Completed - Clinical trials for Behavioural and Psychiatric Symptoms of Dementia

Effectiveness of Home-based Aromatherapy for BPSD

Start date: August 18, 2021
Phase: N/A
Study type: Interventional

Behavioral and psychological symptoms of dementia (BPSD) is the most prominent and distressing manifestation for older persons with dementia (PWD) and caregivers. Aromatherapy was a potentially safe and effective non-pharmacological strategy in BPSD management and could provide benefits to PWD and caregivers. In Hong Kong, some Residential Care Homes for the Elderly and day care centres have provided aromatherapy service to the PWD receiving service from them. However, no such service was provided to the community-dwelling PWD living at home, which constitute a larger proportion of dementia population in HK. In addition, there is no clear implementation protocol, or formal training to the family caregivers to deliver aromatherapy to PWD in home-based setting. Therefore, this study aims to develop and evaluate the effectiveness of a home-based family caregiver-delivered aromatherapy programme for the management of BPSD. PWD ≥ 60-year-old, with BPSD symptoms, and living at home, as well as their family caregivers will be recruited. Participants who pass the screening are randomly allocated to intervention or control group. Those in the intervention group receive home-based aromatherapy programme. Those in the control group receive no intervention for 3-week control period, and then receive home-based aromatherapy programme. The outcome measures will be conducted at baseline and after the 3-week intervention/control period by using Chinese versions of Neuropsychiatric Inventory (CNPI), Chinese version of Dementia QoL Measure-Proxy (C-DEMQoL-Proxy), and Chinese version of Zarit Burden Interview (CZBI).